Results 151 to 160 of about 1,848 (184)

Macitentan/selexipag

Reactions Weekly, 2021
openaire   +1 more source

The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study

European Journal of Heart Failure, 2022
Stephan Rosenkranz, Marius M Hoeper, Victor Tapson   +2 more
exaly  

Selexipag and the pulmonary hypertension continuum

European Journal of Heart Failure, 2021
openaire   +2 more sources

Selexipag/treprostinil

Reactions Weekly, 2019
openaire   +2 more sources

Macitentan/riociguat/selexipag

Reactions Weekly, 2021
openaire   +1 more source

Selexipag/treprostinil

Reactions Weekly, 2017
openaire   +1 more source

Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects

British Journal of Clinical Pharmacology, 2015
Jasper Dingemanse, Shirin Bruderer, Atef Halabi   +2 more
exaly  

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

Journal of Heart and Lung Transplantation, 2019
Raymond L Benza, Harrison W Farber, Kelly M Chin   +2 more
exaly  

Macitentan/selexipag/tadalafil

Reactions Weekly, 2022
openaire   +1 more source

Macitentan/selexipag/tadalafil

Reactions Weekly, 2023
openaire   +1 more source